Suppr超能文献

利用健康计划数据将母婴关联起来以研究妊娠结局的方法。

Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes.

机构信息

Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):776-82. doi: 10.1002/pds.3443. Epub 2013 Apr 18.

Abstract

PURPOSE

Research on medication safety in pregnancy often utilizes health plan and birth certificate records. This study discusses methods used to link mothers with infants, a crucial step in such research.

METHODS

We describe how eight sites participating in the Medication Exposure in Pregnancy Risk Evaluation Program created linkages between deliveries, infants and birth certificates for the 2001-2007 birth cohorts. We describe linkage rates across sites, and for two sites, we compare the characteristics of populations linked using different methods.

RESULTS

Of 299,260 deliveries, 256,563 (86%; range by site, 74-99%) could be linked to infants using a deterministic algorithm. At two sites, using birth certificate data to augment mother-infant linkage increased the representation of mothers who were Hispanic or non-White, younger, Medicaid recipients, or had low educational level. A total of 236,460 (92%; range by site, 82-100%) deliveries could be linked to a birth certificate.

CONCLUSIONS

Tailored approaches enabled linking most deliveries to infants and to birth certificates, even when data systems differed. The methods used may affect the composition of the population identified. Linkages established with such methods can support sound pharmacoepidemiology studies of maternal drug exposure outside the context of a formal registry.

摘要

目的

药物安全性的研究在怀孕时经常利用健康计划和出生证明记录。本研究讨论了将母亲与婴儿联系起来的方法,这是此类研究的关键步骤。

方法

我们描述了参与药物暴露妊娠风险评估计划的 8 个站点如何为 2001-2007 年出生队列创建分娩、婴儿和出生证明之间的联系。我们描述了各站点的联系率,并在两个站点比较了使用不同方法联系的人群特征。

结果

在 299260 例分娩中,256563 例(86%;各站点范围为 74%-99%)可以使用确定性算法与婴儿联系。在两个站点,使用出生证明数据来增加母亲-婴儿联系,增加了西班牙裔或非白种人、年轻、医疗补助受助人或教育程度低的母亲的代表性。共有 236460 例(92%;各站点范围为 82%-100%)分娩可以与出生证明联系。

结论

即使数据系统不同,有针对性的方法也可以使大多数分娩与婴儿和出生证明联系起来。所使用的方法可能会影响所确定人群的构成。使用这些方法建立的联系可以支持在正式登记册之外对母亲药物暴露进行合理的药物流行病学研究。

相似文献

引用本文的文献

10
Power in numbers.人多力量大。
Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v40-v47. doi: 10.1093/rheumatology/key111.

本文引用的文献

1
Medication Exposure in Pregnancy Risk Evaluation Program.妊娠期暴露用药风险评估计划。
Matern Child Health J. 2012 Oct;16(7):1349-54. doi: 10.1007/s10995-011-0902-x.
2
Evolving knowledge of the teratogenicity of medications in human pregnancy.在人类妊娠中药物致畸性的知识不断发展。
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):175-82. doi: 10.1002/ajmg.c.30313. Epub 2011 Jul 15.
7
Design of a national distributed health data network.国家分布式健康数据网络的设计
Ann Intern Med. 2009 Sep 1;151(5):341-4. doi: 10.7326/0003-4819-151-5-200909010-00139. Epub 2009 Jul 28.
10
Outpatient use of cardiovascular drugs during pregnancy.孕期心血管药物的门诊使用。
Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):240-7. doi: 10.1002/pds.1550.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验